LATTICE MEDICAL

IF WE combine biomaterials, tissue engineering and 3D printing technologies, can we create advanced surgical solutions for breast reconstruction?

Lattice Medical developing patient-specific surgical implants with tissue engineering and 3D printing > Dassault Systèmes

Challenge

Why settle for limited options in breast reconstruction? That's where LATTICE MEDICAL comes in. With MATTISSE, a bio-resorbable chamber for natural and customized breast reconstruction, Lattice Medical is revolutionizing the field. 

Disruptive Innovation

Breast cancer is the most generally occurring cancer in women and the second most common cancer overall. In 2020, there were around 2.3 million women diagnosed with breast cancer. Due to the limits of the current techniques, only 20% of women who have a mastectomy (240’000 each year in developed countries), will benefit from breast reconstruction. LATTICE MEDICAL aims to answer to this need with its first patented technology, MATTISSE. Resulting from 6 years of research, MATTISSE is a bio-resorbable, tissue engineered chamber that allows a natural, customized breast reconstruction.

Alongside MATTISSE’s breakthrough technology, LATTICE MEDICAL wants to propose a digital platform for breast reconstruction. Besides providing a surgical decision support tool to choose the implant of the right size for breast surgery, the digital tool will allow clinicians to generate a custom made MATTISSE prothesis suitable for each patient’s unique anatomy. The platform will also provide surgeons with a 3D rendered preoperative view of the patient before and after breast surgery.

sdg-3-8

Impact

LATTICE MEDICAL develops innovative soft tissue reconstruction technologies that enhance patient care and promote economic growth, supporting the following UN Sustainable Development Goals:

  • SDG 3 – Good Health and Well-Being: LATTICE MEDICAL strengthens early detection, risk reduction, and management of breast cancer, improves treatment with reconstructive solutions, and supports healthcare professional training to enhance patient care pathways.
  • SDG 8 – Decent Work and Economic Growth: By leveraging technological innovation, LATTICE MEDICAL fosters inclusive economic growth, creates productive employment opportunities, and contributes to a skilled and empowered healthcare workforce.

Leveraging the 3DEXPERIENCE platform

LATTICE MEDICAL believes in digital transformation as a mean to achieve and preserve high quality, communicative and patient-centered healthcare to respond to unmet clinical needs. As we want to propose a digital tool to provide a surgical decision support tool for implant’s choice in breast reconstruction surgery, 3DEXCITE will be a useful instrument for patient 3D rendering.

Moreover, the 3DEXPERIENCE platform supports the whole product development process at LATTICE MEDICAL. On the platform, all of the necessary tools for product 3D modelling and customization (Solidworks and Catia), biomechanical simulation (Simulia) and production scale up (Delmia) are available on one collaborative environment. In addition, thanks to its marketing and communication tools, we can highlight and promote our products.

Collaborative & Collective Intelligence

Besides being an remarkable platform for product development and enhancement, the 3DEXPERIENCE Platform is also a key resource to improve our team collaboration and communication. When developing innovative technologies like MATTISSE, sharing ideas and strategies is crucial. As we deal with complex projects that require cross-functional teams, this cooperative environment fits perfectly our needs. the 3DEXPERIENCE platform not only gives access to the specific tools for each professional role in our team, but also allows to create shared work environments that boost project collaboration and help achieve our goals in a simpler and more efficient way.

LATTICE MEDICAL

LATTICE MEDICAL

Founded in 2017, LATTICE MEDICAL is a French start-up whose goal is to provide patients and healthcare professionals with customized tissue reconstruction solutions thanks to the combination of biomaterials, tissue engineering and 3D printing technologies.

Meet the Team

Julien Payen
CEO and Co-Founder
Philippe Marchetti
Co-founder & Biologist
Pierre Guerreschi
Co-founder, Plastic Surgeon
Pierre-Marie Danze
Co-founder, CSO
Jaime Destouesse
R&D Manager
Chloé Gigon
Industrialization and Methods Manager
Shengheng Cao
Biomedical Engineer
Kevin Trinh
PhD candidate
Emanuela Basile
Junior Product Manager

Explore Our Portfolio

Submit Your Application

Interested? Take your chance to elevate your project to the next level.